Courtney Standifird
Family · Avondale, AZNPI 1023556578
Payments from drug & device makers
Across 211 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$800
- AbbVie$709
- Boehringer Ingelheim$392
- Dexcom, Inc.$274
- GSK$243
- Novo Nordisk$218
- plus $2K from 28 others
What the payments were for
- Consulting fees$80019%
- Food & beverage$3,50981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $800 |
| AbbVie | 64 | $709 |
| Boehringer Ingelheim | 24 | $392 |
| Dexcom, Inc. | 9 | $274 |
| GSK | 14 | $243 |
| Novo Nordisk | 12 | $218 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $209 |
| Amgen(2 entities) | 10 | $161 |
| Corcept Therapeutics | 4 | $110 |
| AstraZeneca | 7 | $105 |
| Vanda Pharmaceuticals Inc. | 3 | $102 |
| Astellas Pharma US Inc | 4 | $87 |
| Xeris Pharmaceuticals, Inc. | 5 | $87 |
| Abbott | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Amarin Pharma, Inc. | 3 | $56 |
| Bayer | 3 | $55 |
| Johnson & Johnson(2 entities) | 3 | $55 |
| Lilly USA, LLC | 4 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Shield Therapeutics Inc | 1 | $45 |
| Merz North America, Inc. | 1 | $42 |
| Alnylam Pharmaceuticals Inc. | 3 | $41 |
| Lundbeck LLC | 2 | $37 |
| Abiomed | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Merck | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
How this compares
$4,309 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $53,515 |
| JardianceEmpagliflozin | 50 | $51,565 |
| VraylarCariprazine Hcl | 29 | $42,287 |
| XifaxanRifaximin | 11 | $33,638 |
| EliquisApixaban | 16 | $28,381 |
| LinzessLinaclotide | 18 | $22,034 |
| FarxigaDapagliflozin Propanediol | 15 | $19,873 |
| MounjaroTirzepatide | 17 | $19,315 |
| Glatiramer Acetate | 12 | $17,939 |
| TrulicityDulaglutide | 11 | $16,268 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 20 | $13,706 |
| Aripiprazole | 36 | $4,845 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 138 | $3,474 |
| Oxycodone Hcl | 207 | $3,372 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $3,282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Linzess | $709 | $64,32147 claims |
| Novo NordiskOzempic | $218 | $53,51550 claims |
| Boehringer IngelheimJardiance | $392 | $51,56550 claims |
| Lilly USA, LLCMounjaro, Trulicity | $51 | $35,58328 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $48 | $33,63811 claims |
| AstraZenecaFarxiga | $105 | $19,87315 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $28 | $13,70620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.
Other family in Avondale
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Keith MorsePrescott$83K
- Celeste FineGilbert$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.